HIV drug resistance to integrase inhibitors in low- and middle-income countries

Joseph Fokam^{1

2

3

4}, Seth Inzaule⁵, Vittorio Colizzi⁶, Carlo-Federico Perno^{1

7}, Jean Kaseya⁸, Nicaise Ndembi^{9

10

11}

Affiliations

¹ Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
² Faculty of Health Sciences, University of Buea, Buea, Cameroon.
³ National HIV Drug Resistance Group, Ministry of Public Health, Yaoundé, Cameroon.
⁴ Faculty of Medicine and Biomedical Sciences, University of Yaoundé-I, Yaoundé, Cameroon.
⁵ Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
⁶ UNESCO Board of Biotechnology, University of Rome Tor Vergata, Rome, Italy.
⁷ Bambino Gesù IRCCS Pediatric Hospital, Rome, Italy.
⁸ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
⁹ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. nicaise.ndembi@ihv.umaryland.edu.
¹⁰ Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. nicaise.ndembi@ihv.umaryland.edu.
¹¹ Kanazawa University, Graduate School of Medical Sciences, Ishikawa, Japan. nicaise.ndembi@ihv.umaryland.edu.

Joseph Fokam et al. Nat Med. 2024 Mar.

. 2024 Mar;30(3):618-619.

doi: 10.1038/s41591-023-02763-0.

Joseph Fokam^{1

2

3

4}, Seth Inzaule⁵, Vittorio Colizzi⁶, Carlo-Federico Perno^{1

7}, Jean Kaseya⁸, Nicaise Ndembi^{9

10

11}

¹ Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
² Faculty of Health Sciences, University of Buea, Buea, Cameroon.
³ National HIV Drug Resistance Group, Ministry of Public Health, Yaoundé, Cameroon.
⁴ Faculty of Medicine and Biomedical Sciences, University of Yaoundé-I, Yaoundé, Cameroon.
⁵ Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
⁶ UNESCO Board of Biotechnology, University of Rome Tor Vergata, Rome, Italy.
⁷ Bambino Gesù IRCCS Pediatric Hospital, Rome, Italy.
⁸ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
⁹ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. nicaise.ndembi@ihv.umaryland.edu.
¹⁰ Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. nicaise.ndembi@ihv.umaryland.edu.
¹¹ Kanazawa University, Graduate School of Medical Sciences, Ishikawa, Japan. nicaise.ndembi@ihv.umaryland.edu.

No abstract available

References

1. The NAMSAL ANRS 12313 Study Group. N. Engl. J. Med 381, 816–826 (2019). - PubMed
1. Shafer R. In 30th International Workshop on HIV Drug Resistance and Treatment Strategies https://go.nature.com/47BYRUZ (2023).
1. Tao K. et al. Viruses 15, 1932 (2023).
1. Xiao MA et al. Antimicrob. Agents Chemother 67, e0138622 (2023). - PMC - PubMed
1. Brenner BG et al. J. Antimicrob. Chemother 71, 1948–1953 (2016). - PMC - PubMed